Friday, September 30, 2005
Bextra Data Suggests All Cox-2 Drugs Pose Heart Risks - vioxx
Bextra Data Suggests All Cox-2 Drugs Pose Heart Risks
Pfizer's McKinnell May Report Stagnant Sales Growth (Update1)
Atlanta Journal Constitution (subscription) - Atlanta,GA,USA
... The other two drugs in this class are Merck & Co.'s Vioxx, which was pulled from the US market in late September after data linked its long-term use to ...
Bloomberg - USA
... pulled its painkiller Vioxx from the market Sept. 30 because of heart risks. McKinnell repeatedly vouched for Celebrex's safety ...Patients should demand full lifetime refunds on Vioxx, COX-2 ...
News Target - Taichung,Taiwan
... bought it? Do you see people getting their money back for all the Vioxx they purchased over the last few years? Of course not. I ...
Dimethaid expects to resubmit drug to FDA
The Globe and Mail - Toronto,ON,Canada
... Inc.'s recall of the arthritis pain drug Vioxx from the market in September over concerns its use could raise the risks of heart attack. ...
Vioxx alternative lifts Abbott Labs' earnings 9 percent
Chicago Sun-Times - Chicago,IL,USA
... quarter profit rose 9 percent on surging sales of the painkiller Mobic, which arthritis patients are using as an alternative to Merck & Co.'s withdrawn Vioxx. ...Attorney General Darrell Mcgraw Announces Expansion Of Vioxx ...
All American Patriots (press release) - Taeby,NA,Sweden
... announced in December of 2004 that pharmaceutical giant Merck had agreed to significantly alter its consumer refund program for unused Vioxx, the popular ...
Painkiller Combo Cut Post-Surgery Morphine Need
Reuters - UK
... To determine if combination treatment with gabapentin (Neurontin) and rofecoxib (Vioxx) -- two analgesic agents with different modes of action -- improves ...
Hundreds of Lawyers Gather at LexisNexis-Sponsored Symposium On ...
PharmaLive.com (press release) - Newtown,PA,USA
To RSVP and obtain credentials for the Vioxx Litigation Conference, please contact Erin Bocherer at 614.825.1796 or erin.bocherer@fahlgren.com. ...
Pfizer Doesn't Give Much Fizz
Motley Fool - USA
... Despite the concerns over COX-2 inhibitors created by Merck's (NYSE: MRK) withdrawal of Vioxx, Celebrex, and Bextra, both reported higher sales. ...Drug companies face poor fourth quarter
Newark Star Ledger - Newark,NJ,USA
The Vioxx withdrawal, litigation and generic competition haunted the country's largest pharmaceutical companies in the fourth quarter and their earnings for ...
